Clinical & Experimental Cardiology
Open Access

MRI Imaging for Accurate Assessment of Heart Failure Severity

Jessica Federer^{* *}Correspondence: Jessica Federer, Department of Medicine, University of Cape Town, Cape Town, South Africa, Email:

Author info »

Description

Heart damage is a serious condition that can lead to heart failure, heart attack, and other cardiovascular diseases. Early detection of heart damage is crucial to prevent further complications and improve the chances of successful treatment. One promising tool in detecting heart damage early is Magnetic Resonance Imaging (MRI). It occurs when the heart cannot pump enough blood to meet the body's needs, leading to symptoms such as fatigue, shortness of breath, and swelling in the legs and ankles. The diagnosis of heart failure typically involves a combination of medical history, physical examination, and imaging tests. However, recent advancements in MRI technology have the potential to revolutionize the way heart failure is diagnosed [1].

Magnetic Resonance Imaging (MRI) is a non-invasive imaging technique that uses a magnetic field and radio waves to create detailed images of the body's organs and tissues. Unlike other imaging tests such as X-rays and CT scans, MRI does not use ionizing radiation, making it safer for patients. MRI can provide high-resolution images of the heart and its structures, including the chambers, valves, and blood vessels [2]. With the development of new MRI techniques, it is now possible to obtain functional and quantitative information about the heart, such as blood flow, tissue perfusion, and strain.

The fundamental utility of MRI inside the assessment of cardiac failure is its capacity to symbolize the underlying disorder primarily based on the pattern and area of scar/interstitial fibrosis the usage of delayed enhancement imaging. Establishing the etiology allows tailoring of treatment consistent with the reason [3-5]. Subendocardial pattern of delayed enhancement is seen in early infarct and a transmural sample is seen in set up infarct, each conforming to a vascular territorial distribution. In acute Myocardial Infarction (MI), T2-weighted images show myocardial edema in the affected vascular territory. In intense acute MI, a dark area may be seen within the more desirable scar because of microvascular obstruction. Non-ischemic styles of enhancement are mid-myocardial (linear, patchy, or at proper ventricular insertion factors), subepicardial, and global subendocardial/transmural. Non-ischemic dilated cardiomyopathy is a analysis of exclusion, made while the left ventricle is dilated, with poor systolic function, but with normal coronary arteries. In 10%-28% of these patients, a mid-myocardial pattern of enhancement is visible within the basal and mid-septum.

However, ischemic scar pattern is visible in 13% of clinically recognized non-ischemic cardiomyopathy. Myocarditis produces cardiac failure in excessive instances. Similarly to worldwide or nearby dysfunction, myocardial edema, and evaluation enhancement (early and not on time) is visible in a midmyocardial or subepicardial distribution. Normally, the enhancement decreases or disappears with time (in 88% of cases), but might also persist from time to time. Sarcoidosis involves the coronary heart in 5%-25% of sufferers and is associated with regional wall-motion abnormalities, myocardial edema, and thickening and mid-myocardial or subepicardial sample of not on time enhancement. The disease interest can be monitored with T2-weighted imaging and, commonly, the areas of behind schedule enhancement decrease following steroid remedy. Hypertrophic cardiomyopathy is characterized by way of diverse styles of myocardial hypertrophy, that is usually asymmetric septal. Another potential benefit of MRI for heart failure diagnosis is its ability to guide treatment decisions. For example, MRI can help identify the underlying cause of heart failure, such as coronary artery disease or valve dysfunction, which may require different treatment approaches. MRI can also help monitor the effectiveness of treatment over time, allowing physicians to make adjustments as needed.

Conclusion

One of the main advantages of MRI for heart failure diagnosis is its ability to detect subtle changes in the heart's structure and function that may not be visible on other imaging tests. For example, MRI can identify early signs of heart damage, such as fibrosis (scarring) and inflammation, which may indicate the presence of heart failure or other cardiovascular conditions. Additionally, MRI can provide a more accurate assessment of the severity of heart failure and its impact on the patient's quality of life.

References

1. Bushberg JT, Boone JM. The essential physics of medical imaging. Lippincott Williams & Wilkins. 2011:20.

   [Google Scholar]

2. Pooley RA. AAPM/RSNA physics tutorial for residents: fundamental physics of MRI. Radiographics. 2005;25(4):1087-1099.

   [Crossref][Google Scholar][Pub Med]

3. McEvoy SH, McCarthy CJ, Lavelle LP, Moran DE, Cantwell CP, Skehan SJ, et al. Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the American Association for the Study of Liver Diseases. Radiographics. 2013;33(6):1653-1668.

   [Crossref][Google Scholar][Pub Med]

4. Matos AP, Velloni F, Ramalho M, AlObaidy M, Rajapaksha A, Semelka RC. Focal liver lesions: practical magnetic resonance imaging approach. World J Hepatol. 2015;7(16):1987-2008.

   [Crossref][Google Scholar]

5. Prasad SR, Wang H, Rosas H, Menias CO, Narra VR, Middleton WD, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics. 2005;25(2):321-331.

   [Crossref][Google Scholar][Pub Med]